Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Depreciation and Depletion (2016 - 2023)

Rocket Pharmaceuticals (RCKT) has disclosed Depreciation and Depletion for 8 consecutive years, with $1.2 million as the latest value for Q3 2023.

  • Quarterly Depreciation and Depletion rose 9.09% to $1.2 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Sep 2023, down 60.87% year-over-year, with the annual reading at $800000.0 for FY2022, N/A changed from the prior year.
  • Depreciation and Depletion hit $1.2 million in Q3 2023 for Rocket Pharmaceuticals, roughly flat from $1.2 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.2 million in Q2 2023 to a low of -$2.1 million in Q4 2022.
  • Historically, Depreciation and Depletion has averaged $408785.7 across 5 years, with a median of $442500.0 in 2020.
  • Biggest five-year swings in Depreciation and Depletion: changed 0.0% in 2019 and later skyrocketed 47.98% in 2023.
  • Year by year, Depreciation and Depletion stood at $101000.0 in 2019, then fell by 0.99% to $100000.0 in 2020, then skyrocketed by 700.0% to $800000.0 in 2021, then plummeted by 362.5% to -$2.1 million in 2022, then surged by 157.14% to $1.2 million in 2023.
  • Business Quant data shows Depreciation and Depletion for RCKT at $1.2 million in Q3 2023, $1.2 million in Q2 2023, and $1.1 million in Q1 2023.